Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy

BACKGROUND: The objective of this analysis was to evaluate the cost-consequence of recombinant human growth hormone (r-hGH) administered via the easypod auto-injector (Merck, Darmstadt, Germany) versus conventional devices in children with growth hormone deficiency in Italy. METHODS: A patient-level...

Descripción completa

Detalles Bibliográficos
Autores principales: Foo, Jason, Maghnie, Mohamad, Colao, Annamaria, Vlachaki, Ioanna, Colombo, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710537/
https://www.ncbi.nlm.nih.gov/pubmed/31692496
http://dx.doi.org/10.2147/CEOR.S195265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710537/
https://www.ncbi.nlm.nih.gov/pubmed/31692496
http://dx.doi.org/10.2147/CEOR.S195265

Ejemplares similares